๐Ÿ’พ Data Updated: 2025 HTS Revision 30 โ€ข Last updated: November 24, 2025

2922.50.25.00 - Other

Details

FieldValue
Unit of Quantitykg
General Rate of Duty6.5%
Special Rate of DutyFree (A+,AU,BH,CL,CO,D,E,IL,JO,K,KR,MA,OM,P,PA,PE,S,SG)
A+ ๐Ÿ‡ฆ๐Ÿ‡ซ ๐Ÿ‡ฆ๐Ÿ‡ด ๐Ÿ‡ง๐Ÿ‡ฏ ๐Ÿ‡ง๐Ÿ‡น ๐Ÿ‡ง๐Ÿ‡ซ ๐Ÿ‡ง๐Ÿ‡ฎ ๐Ÿ‡ฐ๐Ÿ‡ญ ๐Ÿ‡จ๐Ÿ‡ซ ๐Ÿ‡น๐Ÿ‡ฉ ๐Ÿ‡ฐ๐Ÿ‡ฒ ๐Ÿ‡จ๐Ÿ‡ฉ ๐Ÿ‡ฉ๐Ÿ‡ฏ ๐Ÿ‡ช๐Ÿ‡น ๐Ÿ‡ฌ๐Ÿ‡ฒ ๐Ÿ‡ฌ๐Ÿ‡ณ ๐Ÿ‡ฌ๐Ÿ‡ผ ๐Ÿ‡ญ๐Ÿ‡น ๐Ÿ‡ฐ๐Ÿ‡ฎ ๐Ÿ‡ฑ๐Ÿ‡ธ ๐Ÿ‡ฑ๐Ÿ‡ท ๐Ÿ‡ฒ๐Ÿ‡ฌ ๐Ÿ‡ฒ๐Ÿ‡ผ ๐Ÿ‡ฒ๐Ÿ‡ฑ ๐Ÿ‡ฒ๐Ÿ‡ท ๐Ÿ‡ฒ๐Ÿ‡ฟ ๐Ÿ‡ฒ๐Ÿ‡ฒ ๐Ÿ‡ณ๐Ÿ‡ต ๐Ÿ‡ณ๐Ÿ‡ช ๐Ÿ‡ท๐Ÿ‡ผ ๐Ÿ‡ผ๐Ÿ‡ธ ๐Ÿ‡ธ๐Ÿ‡ณ ๐Ÿ‡ธ๐Ÿ‡ฑ ๐Ÿ‡ธ๐Ÿ‡ง ๐Ÿ‡ธ๐Ÿ‡ด ๐Ÿ‡ธ๐Ÿ‡ธ ๐Ÿ‡ธ๐Ÿ‡น ๐Ÿ‡น๐Ÿ‡ฟ ๐Ÿ‡น๐Ÿ‡ฑ ๐Ÿ‡น๐Ÿ‡ฌ ๐Ÿ‡น๐Ÿ‡ป ๐Ÿ‡บ๐Ÿ‡ฌ ๐Ÿ‡ป๐Ÿ‡บ ๐Ÿ‡พ๐Ÿ‡ช ๐Ÿ‡ฟ๐Ÿ‡ฒ
AU ๐Ÿ‡ฆ๐Ÿ‡บ
BH ๐Ÿ‡ง๐Ÿ‡ญ
CL ๐Ÿ‡จ๐Ÿ‡ฑ
CO ๐Ÿ‡จ๐Ÿ‡ด
D ๐Ÿ‡ฆ๐Ÿ‡ด ๐Ÿ‡ง๐Ÿ‡ฏ ๐Ÿ‡ง๐Ÿ‡ผ ๐Ÿ‡ง๐Ÿ‡ซ ๐Ÿ‡จ๐Ÿ‡ป ๐Ÿ‡จ๐Ÿ‡ซ ๐Ÿ‡น๐Ÿ‡ฉ ๐Ÿ‡ฐ๐Ÿ‡ฒ ๐Ÿ‡จ๐Ÿ‡ฎ ๐Ÿ‡จ๐Ÿ‡ฉ ๐Ÿ‡ฉ๐Ÿ‡ฏ ๐Ÿ‡ธ๐Ÿ‡ฟ ๐Ÿ‡ช๐Ÿ‡น ๐Ÿ‡ฌ๐Ÿ‡ฆ ๐Ÿ‡ฌ๐Ÿ‡ฒ ๐Ÿ‡ฌ๐Ÿ‡ญ ๐Ÿ‡ฌ๐Ÿ‡ณ ๐Ÿ‡ฌ๐Ÿ‡ผ ๐Ÿ‡ฐ๐Ÿ‡ช ๐Ÿ‡ฑ๐Ÿ‡ธ ๐Ÿ‡ฑ๐Ÿ‡ท ๐Ÿ‡ฒ๐Ÿ‡ฌ ๐Ÿ‡ฒ๐Ÿ‡ผ ๐Ÿ‡ฒ๐Ÿ‡ฑ ๐Ÿ‡ฒ๐Ÿ‡บ ๐Ÿ‡ฒ๐Ÿ‡ฟ ๐Ÿ‡ณ๐Ÿ‡ฆ ๐Ÿ‡ณ๐Ÿ‡ช ๐Ÿ‡ณ๐Ÿ‡ฌ ๐Ÿ‡จ๐Ÿ‡ฌ ๐Ÿ‡ท๐Ÿ‡ผ ๐Ÿ‡ธ๐Ÿ‡ณ ๐Ÿ‡ธ๐Ÿ‡ฑ ๐Ÿ‡ฟ๐Ÿ‡ฆ ๐Ÿ‡ธ๐Ÿ‡น ๐Ÿ‡น๐Ÿ‡ฟ ๐Ÿ‡น๐Ÿ‡ฌ ๐Ÿ‡บ๐Ÿ‡ฌ ๐Ÿ‡ฟ๐Ÿ‡ฒ
E ๐Ÿ‡ฆ๐Ÿ‡ฌ ๐Ÿ‡ฆ๐Ÿ‡ผ ๐Ÿ‡ง๐Ÿ‡ธ ๐Ÿ‡ง๐Ÿ‡ง ๐Ÿ‡ง๐Ÿ‡ฟ ๐Ÿ‡ป๐Ÿ‡ฌ ๐Ÿ‡จ๐Ÿ‡ผ ๐Ÿ‡ฉ๐Ÿ‡ฒ ๐Ÿ‡ฌ๐Ÿ‡ฉ ๐Ÿ‡ฌ๐Ÿ‡พ ๐Ÿ‡ญ๐Ÿ‡น ๐Ÿ‡ฏ๐Ÿ‡ฒ ๐Ÿ‡ฒ๐Ÿ‡ธ NE ๐Ÿ‡ฐ๐Ÿ‡ณ ๐Ÿ‡ฑ๐Ÿ‡จ ๐Ÿ‡ป๐Ÿ‡จ ๐Ÿ‡น๐Ÿ‡น
IL ๐Ÿ‡ฎ๐Ÿ‡ฑ
JO ๐Ÿ‡ฏ๐Ÿ‡ด
K ๐Ÿ‡ฆ๐Ÿ‡ซ ๐Ÿ‡ฆ๐Ÿ‡ฑ ๐Ÿ‡ฆ๐Ÿ‡ฉ ๐Ÿ‡ฆ๐Ÿ‡ด ๐Ÿ‡ฆ๐Ÿ‡ฎ ๐Ÿ‡ฆ๐Ÿ‡ฌ ๐Ÿ‡ฆ๐Ÿ‡ท ๐Ÿ‡ฆ๐Ÿ‡ฒ ๐Ÿ‡ฆ๐Ÿ‡ผ ๐Ÿ‡ฆ๐Ÿ‡บ ๐Ÿ‡ฆ๐Ÿ‡น ๐Ÿ‡ฆ๐Ÿ‡ฟ ๐Ÿ‡ง๐Ÿ‡ธ ๐Ÿ‡ง๐Ÿ‡ญ ๐Ÿ‡ง๐Ÿ‡ฉ ๐Ÿ‡ง๐Ÿ‡ง ๐Ÿ‡ง๐Ÿ‡พ ๐Ÿ‡ง๐Ÿ‡ช ๐Ÿ‡ง๐Ÿ‡ฟ ๐Ÿ‡ง๐Ÿ‡ฏ ๐Ÿ‡ง๐Ÿ‡ฒ ๐Ÿ‡ง๐Ÿ‡น ๐Ÿ‡ง๐Ÿ‡ด ๐Ÿ‡ง๐Ÿ‡ฆ ๐Ÿ‡ง๐Ÿ‡ผ ๐Ÿ‡ง๐Ÿ‡ท ๐Ÿ‡ฎ๐Ÿ‡ด ๐Ÿ‡ป๐Ÿ‡ฌ ๐Ÿ‡ง๐Ÿ‡ณ ๐Ÿ‡ง๐Ÿ‡ฌ ๐Ÿ‡ง๐Ÿ‡ซ ๐Ÿ‡ง๐Ÿ‡ฎ ๐Ÿ‡จ๐Ÿ‡ป ๐Ÿ‡ฐ๐Ÿ‡ญ ๐Ÿ‡จ๐Ÿ‡ฒ ๐Ÿ‡จ๐Ÿ‡ฆ ๐Ÿ‡ฐ๐Ÿ‡พ ๐Ÿ‡จ๐Ÿ‡ซ ๐Ÿ‡น๐Ÿ‡ฉ ๐Ÿ‡จ๐Ÿ‡ฑ ๐Ÿ‡จ๐Ÿ‡ณ ๐Ÿ‡จ๐Ÿ‡ฝ ๐Ÿ‡จ๐Ÿ‡จ ๐Ÿ‡จ๐Ÿ‡ด ๐Ÿ‡ฐ๐Ÿ‡ฒ ๐Ÿ‡จ๐Ÿ‡ฐ ๐Ÿ‡จ๐Ÿ‡ท ๐Ÿ‡ญ๐Ÿ‡ท ๐Ÿ‡จ๐Ÿ‡พ ๐Ÿ‡จ๐Ÿ‡ฟ ๐Ÿ‡จ๐Ÿ‡ฟ ๐Ÿ‡จ๐Ÿ‡ฎ ๐Ÿ‡จ๐Ÿ‡ฉ ๐Ÿ‡ฉ๐Ÿ‡ฐ ๐Ÿ‡ฉ๐Ÿ‡ฏ ๐Ÿ‡ฉ๐Ÿ‡ฒ ๐Ÿ‡ฉ๐Ÿ‡ด EA ๐Ÿ‡ช๐Ÿ‡จ ๐Ÿ‡ช๐Ÿ‡ฌ ๐Ÿ‡ธ๐Ÿ‡ป ๐Ÿ‡ฌ๐Ÿ‡ถ ๐Ÿ‡ช๐Ÿ‡ท ๐Ÿ‡ช๐Ÿ‡ช ๐Ÿ‡ธ๐Ÿ‡ฟ ๐Ÿ‡ช๐Ÿ‡น ET ๐Ÿ‡ซ๐Ÿ‡ฐ ๐Ÿ‡ซ๐Ÿ‡ด ๐Ÿ‡ซ๐Ÿ‡ฏ ๐Ÿ‡ซ๐Ÿ‡ฎ ๐Ÿ‡ซ๐Ÿ‡ท ๐Ÿ‡ฌ๐Ÿ‡ซ ๐Ÿ‡ต๐Ÿ‡ซ ๐Ÿ‡น๐Ÿ‡ซ ๐Ÿ‡ฌ๐Ÿ‡ฆ ๐Ÿ‡ฌ๐Ÿ‡ฒ ๐Ÿ‡ต๐Ÿ‡ธ ๐Ÿ‡ฌ๐Ÿ‡ช ๐Ÿ‡ฉ๐Ÿ‡ช ๐Ÿ‡ฌ๐Ÿ‡ญ ๐Ÿ‡ฌ๐Ÿ‡ฎ ๐Ÿ‡ฌ๐Ÿ‡ท ๐Ÿ‡ฌ๐Ÿ‡ฑ ๐Ÿ‡ฌ๐Ÿ‡ฉ ๐Ÿ‡ฌ๐Ÿ‡ต ๐Ÿ‡ฌ๐Ÿ‡น ๐Ÿ‡ฌ๐Ÿ‡ณ ๐Ÿ‡ฌ๐Ÿ‡ผ ๐Ÿ‡ฌ๐Ÿ‡พ ๐Ÿ‡ญ๐Ÿ‡น ๐Ÿ‡ญ๐Ÿ‡ฒ ๐Ÿ‡ญ๐Ÿ‡ณ ๐Ÿ‡ญ๐Ÿ‡ฐ ๐Ÿ‡ญ๐Ÿ‡บ ๐Ÿ‡ฎ๐Ÿ‡ธ ๐Ÿ‡ฎ๐Ÿ‡ณ ๐Ÿ‡ฎ๐Ÿ‡ฉ IN ๐Ÿ‡ฎ๐Ÿ‡ท ๐Ÿ‡ฎ๐Ÿ‡ถ ๐Ÿ‡ฎ๐Ÿ‡ช ๐Ÿ‡ฎ๐Ÿ‡ฑ IS ๐Ÿ‡ฎ๐Ÿ‡น ๐Ÿ‡ฏ๐Ÿ‡ฒ ๐Ÿ‡ฏ๐Ÿ‡ต ๐Ÿ‡ฏ๐Ÿ‡ด ๐Ÿ‡ฐ๐Ÿ‡ฟ ๐Ÿ‡ฐ๐Ÿ‡ช ๐Ÿ‡ฐ๐Ÿ‡ฎ KO ๐Ÿ‡ฐ๐Ÿ‡ผ ๐Ÿ‡ฐ๐Ÿ‡ฌ ๐Ÿ‡ฑ๐Ÿ‡ฆ ๐Ÿ‡ฑ๐Ÿ‡ป ๐Ÿ‡ฑ๐Ÿ‡ง ๐Ÿ‡ฑ๐Ÿ‡ธ ๐Ÿ‡ฑ๐Ÿ‡ท ๐Ÿ‡ฑ๐Ÿ‡พ ๐Ÿ‡ฑ๐Ÿ‡ฎ ๐Ÿ‡ฑ๐Ÿ‡น ๐Ÿ‡ฑ๐Ÿ‡บ ๐Ÿ‡ฒ๐Ÿ‡ด ๐Ÿ‡ฒ๐Ÿ‡ฌ ๐Ÿ‡ฒ๐Ÿ‡ผ ๐Ÿ‡ฒ๐Ÿ‡พ ๐Ÿ‡ฒ๐Ÿ‡ป ๐Ÿ‡ฒ๐Ÿ‡ฑ ๐Ÿ‡ฒ๐Ÿ‡น ๐Ÿ‡ฒ๐Ÿ‡ญ ๐Ÿ‡ฒ๐Ÿ‡ถ ๐Ÿ‡ฒ๐Ÿ‡ท ๐Ÿ‡ฒ๐Ÿ‡บ ๐Ÿ‡พ๐Ÿ‡น ๐Ÿ‡ฒ๐Ÿ‡ฝ ๐Ÿ‡ซ๐Ÿ‡ฒ ๐Ÿ‡ฒ๐Ÿ‡ฉ ๐Ÿ‡ฒ๐Ÿ‡จ ๐Ÿ‡ฒ๐Ÿ‡ณ ๐Ÿ‡ฒ๐Ÿ‡ช ๐Ÿ‡ฒ๐Ÿ‡ธ ๐Ÿ‡ฒ๐Ÿ‡ฆ ๐Ÿ‡ฒ๐Ÿ‡ฟ ๐Ÿ‡ฒ๐Ÿ‡ฒ ๐Ÿ‡ณ๐Ÿ‡ฆ ๐Ÿ‡ณ๐Ÿ‡ท ๐Ÿ‡ณ๐Ÿ‡ต ๐Ÿ‡ณ๐Ÿ‡ฑ NE ๐Ÿ‡ณ๐Ÿ‡จ ๐Ÿ‡ณ๐Ÿ‡ฟ ๐Ÿ‡ณ๐Ÿ‡ฎ ๐Ÿ‡ณ๐Ÿ‡ช ๐Ÿ‡ณ๐Ÿ‡ฌ ๐Ÿ‡ณ๐Ÿ‡บ ๐Ÿ‡ณ๐Ÿ‡ซ ๐Ÿ‡ฒ๐Ÿ‡ฐ ๐Ÿ‡ณ๐Ÿ‡ด ๐Ÿ‡ด๐Ÿ‡ฒ ๐Ÿ‡ต๐Ÿ‡ฐ ๐Ÿ‡ต๐Ÿ‡ผ ๐Ÿ‡ต๐Ÿ‡ฆ ๐Ÿ‡ต๐Ÿ‡ฌ ๐Ÿ‡ต๐Ÿ‡พ ๐Ÿ‡ต๐Ÿ‡ช ๐Ÿ‡ต๐Ÿ‡ญ ๐Ÿ‡ต๐Ÿ‡ณ ๐Ÿ‡ต๐Ÿ‡ฑ ๐Ÿ‡ต๐Ÿ‡น ๐Ÿ‡ต๐Ÿ‡ท ๐Ÿ‡ถ๐Ÿ‡ฆ ๐Ÿ‡จ๐Ÿ‡ฌ ๐Ÿ‡ท๐Ÿ‡ช ๐Ÿ‡ท๐Ÿ‡ด ๐Ÿ‡ท๐Ÿ‡บ ๐Ÿ‡ท๐Ÿ‡ผ ๐Ÿ‡ธ๐Ÿ‡ญ ๐Ÿ‡ฐ๐Ÿ‡ณ ๐Ÿ‡ฑ๐Ÿ‡จ ๐Ÿ‡ต๐Ÿ‡ฒ ๐Ÿ‡ป๐Ÿ‡จ ๐Ÿ‡ผ๐Ÿ‡ธ ๐Ÿ‡ธ๐Ÿ‡ฒ ๐Ÿ‡ธ๐Ÿ‡ฆ SA ๐Ÿ‡ธ๐Ÿ‡ณ ๐Ÿ‡ท๐Ÿ‡ธ SE SE ๐Ÿ‡ธ๐Ÿ‡จ ๐Ÿ‡ธ๐Ÿ‡ฑ ๐Ÿ‡ธ๐Ÿ‡ฌ ๐Ÿ‡ธ๐Ÿ‡ฐ ๐Ÿ‡ธ๐Ÿ‡ฎ ๐Ÿ‡ธ๐Ÿ‡ง ๐Ÿ‡ธ๐Ÿ‡ด ๐Ÿ‡ฟ๐Ÿ‡ฆ ๐Ÿ‡ฐ๐Ÿ‡ท ๐Ÿ‡ธ๐Ÿ‡ธ SO SO ๐Ÿ‡ช๐Ÿ‡ธ ๐Ÿ‡ฑ๐Ÿ‡ฐ ๐Ÿ‡ธ๐Ÿ‡ฉ SU ๐Ÿ‡ธ๐Ÿ‡ท ๐Ÿ‡ธ๐Ÿ‡ฏ ๐Ÿ‡ธ๐Ÿ‡ช ๐Ÿ‡จ๐Ÿ‡ญ ๐Ÿ‡ธ๐Ÿ‡พ ๐Ÿ‡ธ๐Ÿ‡น ๐Ÿ‡น๐Ÿ‡ผ ๐Ÿ‡น๐Ÿ‡ฏ ๐Ÿ‡น๐Ÿ‡ฟ ๐Ÿ‡น๐Ÿ‡ญ ๐Ÿ‡น๐Ÿ‡ฑ ๐Ÿ‡น๐Ÿ‡ฌ ๐Ÿ‡น๐Ÿ‡ฐ ๐Ÿ‡น๐Ÿ‡ด TR ๐Ÿ‡น๐Ÿ‡น ๐Ÿ‡น๐Ÿ‡ณ ๐Ÿ‡น๐Ÿ‡ท ๐Ÿ‡น๐Ÿ‡ฒ ๐Ÿ‡น๐Ÿ‡จ ๐Ÿ‡น๐Ÿ‡ป ๐Ÿ‡บ๐Ÿ‡ฌ ๐Ÿ‡บ๐Ÿ‡ฆ ๐Ÿ‡ฆ๐Ÿ‡ช ๐Ÿ‡ฌ๐Ÿ‡ง UN ๐Ÿ‡บ๐Ÿ‡พ ๐Ÿ‡บ๐Ÿ‡ฟ ๐Ÿ‡ป๐Ÿ‡บ ๐Ÿ‡ป๐Ÿ‡ฆ ๐Ÿ‡ป๐Ÿ‡ช ๐Ÿ‡ป๐Ÿ‡ณ ๐Ÿ‡ผ๐Ÿ‡ซ ๐Ÿ‡ต๐Ÿ‡ธ ๐Ÿ‡ช๐Ÿ‡ญ ๐Ÿ‡พ๐Ÿ‡ช ๐Ÿ‡ฟ๐Ÿ‡ฒ ๐Ÿ‡ฟ๐Ÿ‡ผ
KR ๐Ÿ‡ฐ๐Ÿ‡ท
MA ๐Ÿ‡ฒ๐Ÿ‡ฆ
OM ๐Ÿ‡ด๐Ÿ‡ฒ
P ๐Ÿ‡จ๐Ÿ‡ท ๐Ÿ‡ฉ๐Ÿ‡ด ๐Ÿ‡ธ๐Ÿ‡ป ๐Ÿ‡ฌ๐Ÿ‡น ๐Ÿ‡ญ๐Ÿ‡ณ ๐Ÿ‡ณ๐Ÿ‡ฎ
PA ๐Ÿ‡ต๐Ÿ‡ฆ
PE ๐Ÿ‡ต๐Ÿ‡ช
S ๐Ÿ‡จ๐Ÿ‡ฆ ๐Ÿ‡ฒ๐Ÿ‡ฝ
SG ๐Ÿ‡ธ๐Ÿ‡ฌ
Column 2 Rate of Duty15.4ยข/kg + 82%
Quota QuantityN/A
Additional DutiesN/A

Overview

This HTS category, 2922.50.25.00, encompasses "Other" amino compounds with oxygen function that are aromatic and are intended for use as drugs, excluding those specifically categorized as cardiovascular drugs, dermatological agents and local anesthetics, or guaiacol derivatives. The classification here applies to aromatic amino compounds with oxygen functionality that do not fit into more precisely defined subheadings within 2922.50. This often includes pharmaceutical intermediates or active pharmaceutical ingredients (APIs) whose primary function is medicinal but are not listed in the more specific drug categories.

The critical distinction of this category lies in its residual nature. Unlike its siblings, which are designated for specific therapeutic classes (e.g., cardiovascular drugs, dermatological agents), this subheading serves as a catch-all for other aromatic amino-oxygen compounds classified as drugs. Therefore, when classifying an aromatic amino-oxygen compound intended for drug use, if it does not meet the criteria for 2922.50.14.00, 2922.50.17.00, or 2922.50.19.00, it would likely fall under this "Other" category, provided it is indeed classified as a drug.

As a leaf node, 2922.50.25.00 does not have further subcategories. Classification within this heading hinges on identifying an aromatic amino compound with an oxygen function that is recognized and intended for medicinal purposes, and for which no more specific HTS classification is available. Examples might include certain broad-spectrum antiviral agents or specific types of antineoplastic agents not otherwise enumerated.

Stay Updated

Join our newsletter to get all updates of the harmonized Tariff Schedule.